A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...

In January, Gov. Kim Reynolds pledged $1 million to fund a team of epidemiologists who would work to understand Iowa’s ...

Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact ...

Patients with gastroesophageal reflux disease are at increased risk of developing lung cancer, according to a study presented at DDW 2025.

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

A Bay Area woman fights back against the odds to raise awareness about lung cancer in Asian American women who have never smoked.

Results from phase 2 trials appear to support the use of chemotherapy-free regimens in patients with osimertinib-resistant NSCLC.

Almost 50,000 lung cancer patients have not been seen on time over the last 10 years, with thousands currently waiting more ...

Dr. Bryant Lin explains how his stage IV lung cancer diagnosis didn’t defeat him but instead inspired a revolutionary class.

Preliminary results from the AACR 2025 Annual Meeting reveal encouraging clinical responses to the investigational oral agent ...